Immatics N.V. (IMTX) stock
IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.39−0.13 (-1.99%)
Close on Nov 13, 2026Market cap $856.72MP/E –Yield –
Immatics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Immatics's enterprise value was $559.23M on Nov 11, 2026, against $843.94M a year earlier. Over the last 5 years it ranged from $106.53M to $1.00B, with a median of $561.31M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $559.23M | -31.8% |
| 2025 | Dec 31, 2025 | $820.16M | +117.6% |
| 2024 | Dec 31, 2024 | $376.85M | -35.1% |
| 2023 | Dec 29, 2023 | $580.47M | +119.6% |
| 2022 | Dec 30, 2022 | $264.34M | -43.0% |
| 2021 | Dec 31, 2021 | $463.94M | +100.1% |
| 2020 | Dec 31, 2020 | $231.90M | -23.0% |
| 2019 | Dec 31, 2019 | $301.33M | – |
See a number that looks wrong?